Effect of novel selective non-peptide kinin B1 receptor antagonists on mouse pleurisy induced by carrageenan

被引:16
|
作者
Costa, Robson
Fernandes, Elizabeth S.
Menezes-De-Lima, Octavio, Jr.
Campos, Maria M.
Calixto, Jodo B.
机构
[1] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-88049900 Florianopolis, SC, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul, Sch Dent, Porto Alegre, RS, Brazil
关键词
B-1; receptor; peptide antagonists; non-peptide antagonists; carrageenan; pleurisy; mice;
D O I
10.1016/j.peptides.2006.07.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two novel selective non-peptide kinin B-1 receptor antagonists, the benzodiazepine antagonist and SSR240612, were evaluated in carrageenan-induced mouse pleurisy. The peptide 8715 (0.5 mg/kg, i.p.) and the non-peptide benzodiazepine (3 mg/kg, i.p.) antagonists significantly decreased cellular migration (predominantly neutrophils), without altering plasma exudation. SSR240612 (1 mg/kg, i.p.) diminished total cells and neutrophils, besides exudation. Oral administration of SSR240612 (10 mg/kg) also reduced total cell and neutrophil counts. Only the benzodiazepine antagonist inhibited the lung myeloperoxidase activity. No tested antagonist significantly altered the lung and pleural TNF alpha and IL-1 beta production. We provide interesting evidence on the anti-inflammatory in vivo effects of non-peptide B-1 receptor antagonists. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:2967 / 2975
页数:9
相关论文
共 50 条
  • [2] Non-peptide antagonists for kinin B1 receptors:: never insights into their therapeutic potential for the management of inflammation and pain
    Campos, Maria M.
    Leal, Paulo C.
    Yunes, Rosendo A.
    Calixto, Joao B.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (12) : 646 - 651
  • [3] Discovery of novel non-peptide CCR1 receptor antagonists
    Ng, HP
    May, K
    Bauman, JG
    Ghannam, A
    Islam, I
    Liang, M
    Horuk, R
    Hesselgesser, J
    Snider, RM
    Perez, HD
    Morrissey, MM
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4680 - 4694
  • [4] Discovery of a potent, non-peptide bradykinin B1 receptor antagonist
    Su, DS
    Markowitz, MK
    DiPardo, RM
    Murphy, KL
    Harrell, CM
    O'Malley, SS
    Ransom, RW
    Chang, RSL
    Ha, S
    Hess, FJ
    Pettibone, DJ
    Mason, GS
    Boyce, S
    Freidinger, RM
    Bock, MG
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (25) : 7516 - 7517
  • [6] Novel non-peptide lead structures for Bradykinin B2-receptor antagonists
    Pineda L.F.
    Liebmann C.
    Hensellek S.
    Paegelow I.
    Steinmetzer T.
    Schweinitz A.
    Stürzebecher J.
    Reissmann S.
    Letters in Peptide Science, 2000, 7 (2): : 69 - 77
  • [7] Novel non-peptide lead structures for Bradykinin B2-receptor antagonists
    Pineda, LF
    Liebmann, C
    Hensellek, S
    Paegelow, I
    Steinmetzer, T
    Schweinitz, A
    Stürzebecher, J
    Reissmann, S
    LETTERS IN PEPTIDE SCIENCE, 2000, 7 (02): : 69 - 77
  • [8] Identification of a key region of kinin B1 receptor for high affinity binding of peptide antagonists
    Bastian, S
    Pruneau, D
    Loillier, B
    Robert, C
    Bonnafous, JC
    Paquet, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) : 6107 - 6113
  • [9] Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice
    Gabra, BH
    Sirois, P
    NEUROPEPTIDES, 2003, 37 (01) : 36 - 44
  • [10] 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor
    Porter, RA
    Chan, WN
    Coulton, S
    Johns, A
    Hadley, MS
    Widdowson, K
    Jerman, JC
    Brough, SJ
    Coldwell, M
    Smart, D
    Jewitt, F
    Jeffrey, P
    Austin, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1907 - 1910